These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31092596)

  • 1. Implications of Bacteriophage- and Bacteriophage Component-Based Therapies for the Clinical Microbiology Laboratory.
    Caflisch KM; Patel R
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31092596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Phage Microbiology: a suggested framework and recommendations for the in-vitro matching steps of phage therapy.
    Gelman D; Yerushalmy O; Alkalay-Oren S; Rakov C; Ben-Porat S; Khalifa L; Adler K; Abdalrhman M; Coppenhagen-Glazer S; Aslam S; Schooley RT; Nir-Paz R; Hazan R
    Lancet Microbe; 2021 Oct; 2(10):e555-e563. PubMed ID: 35544180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophages as Therapeutic Preparations: What Restricts Their Application in Medicine.
    Vlassov VV; Tikunova NV; Morozova VV
    Biochemistry (Mosc); 2020 Nov; 85(11):1350-1361. PubMed ID: 33280578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophage therapy: recent developments and applications of a renaissant weapon.
    Fathima B; Archer AC
    Res Microbiol; 2021; 172(6):103863. PubMed ID: 34293451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope.
    Kulshrestha M; Tiwari M; Tiwari V
    Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophage therapy for management of bacterial infections in veterinary practice: what was once old is new again.
    Squires RA
    N Z Vet J; 2018 Sep; 66(5):229-235. PubMed ID: 29925297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacteriophage Therapy: Retrospective Review and Future Prospects].
    Tian EK; Wang Y; Wu ZX; Wan ZQ; Cheng W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):170-175. PubMed ID: 33829687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of bacteriophage therapy in the treatment of paediatric respiratory infections.
    Jones JD; Varghese D; Pabary R; Langley RJ
    Paediatr Respir Rev; 2022 Dec; 44():70-77. PubMed ID: 35241371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophage therapy for challenging bacterial infections: achievements, limitations and prospects for future clinical use by veterinary dermatologists.
    Squires RA
    Vet Dermatol; 2021 Dec; 32(6):587-e158. PubMed ID: 33870572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic bacteriophages as a rescue treatment for drug-resistant infections - an in vivo studies overview.
    Kwiatek M; Parasion S; Nakonieczna A
    J Appl Microbiol; 2020 Apr; 128(4):985-1002. PubMed ID: 31778593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to optimize therapeutic bacteriophage and bacteriophage-derived products to combat bacterial infections.
    Reuter M; Kruger DH
    Virus Genes; 2020 Apr; 56(2):136-149. PubMed ID: 32036540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacteriophage Therapy of Urological Infections].
    Perepanova TS; Merinov DS; Kazachenko AV; Khazan PL; Malova YA
    Urologiia; 2020 Nov; (5):106-114. PubMed ID: 33185357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy.
    Yeh TK; Jean SS; Lee YL; Lu MC; Ko WC; Lin HJ; Liu PY; Hsueh PR
    Int J Antimicrob Agents; 2022 Jan; 59(1):106475. PubMed ID: 34767917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.
    Kakasis A; Panitsa G
    Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and clinical importance of bacteriophage resistance.
    Egido JE; Costa AR; Aparicio-Maldonado C; Haas PJ; Brouns SJJ
    FEMS Microbiol Rev; 2022 Feb; 46(1):. PubMed ID: 34558600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophage as an antibacterial agent: a patent perspective.
    Pathak-Vaidya P; Sharma S; Telang M
    Future Microbiol; 2021 Nov; 16():1327-1339. PubMed ID: 34755539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Back to the future: bacteriophages as promising therapeutic tools.
    Domingo-Calap P; Georgel P; Bahram S
    HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological foundations of successful bacteriophage therapy.
    Venturini C; Petrovic Fabijan A; Fajardo Lubian A; Barbirz S; Iredell J
    EMBO Mol Med; 2022 Jul; 14(7):e12435. PubMed ID: 35620963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.